The Carlat Psychiatry Podcast
How to Combat Tardive Dyskinesia with VMAT2 Inhibitors
For years, we have dreaded seeing our patients develop antipsychotic-induced tardive dyskinesia because there was little we could do about these symptoms. Thankfully, we now have new treatments that produce noticeable improvements in tardive dyskinesia.
CME: Clinicians enrolled in our Podcast CME Subscription can access the post-test here.
Published On: 12/15/2021
Duration: 11 minutes, 23 seconds
Referenced Article: “Finally, Effective Treatments for Tardive Dyskinesia,” The Carlat Hospital Psychiatry Report, April/May/June 2021
Victoria Hendrick, MD, and Zachary Davis, BS, have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.